BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22184303)

  • 1. Impact of localization studies and clinical scenario in patients with hyperparathyroidism being evaluated for reoperative neck surgery.
    Shin JJ; Milas M; Mitchell J; Berber E; Ross L; Siperstein A
    Arch Surg; 2011 Dec; 146(12):1397-403. PubMed ID: 22184303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reoperative parathyroidectomy: an algorithm for imaging and monitoring of intraoperative parathyroid hormone levels that results in a successful focused approach.
    Yen TW; Wang TS; Doffek KM; Krzywda EA; Wilson SD
    Surgery; 2008 Oct; 144(4):611-9; discussion 619-21. PubMed ID: 18847646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of preoperative localization studies and intraoperative parathyroid hormone assay in patients with primary hyperparathyroidism and double adenoma.
    Haciyanli M; Lal G; Morita E; Duh QY; Kebebew E; Clark OH
    J Am Coll Surg; 2003 Nov; 197(5):739-46. PubMed ID: 14585407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sestamibi scans and intraoperative parathyroid hormone measurement in the treatment of primary hyperparathyroidism.
    Bergson EJ; Sznyter LA; Dubner S; Palestro CJ; Heller KS
    Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):87-91. PubMed ID: 14732775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience.
    Grant CS; Thompson G; Farley D; van Heerden J
    Arch Surg; 2005 May; 140(5):472-8; discussion 478-9. PubMed ID: 15897443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism.
    Siperstein A; Berber E; Mackey R; Alghoul M; Wagner K; Milas M
    Surgery; 2004 Oct; 136(4):872-80. PubMed ID: 15467674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary hyperparathyroidism.
    Felger EA; Kandil E
    Otolaryngol Clin North Am; 2010 Apr; 43(2):417-32, x. PubMed ID: 20510724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tertiary hyperparathyroidism: histologic patterns of disease and results of parathyroidectomy.
    Kebebew E; Duh QY; Clark OH
    Arch Surg; 2004 Sep; 139(9):974-7. PubMed ID: 15381615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy.
    Ugur O; Bozkurt MF; Hamaloglu E; Sokmensuer C; Etikan I; Ugur Y; Sayek I; Gulec SA
    Arch Surg; 2004 Nov; 139(11):1175-9. PubMed ID: 15545562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reoperative parathyroid surgery.
    Grant CS; Charboneau JW; James EM; Reading CC
    Wien Klin Wochenschr; 1988 May; 100(11):360-3. PubMed ID: 2900581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Low dose' 99mTc-Sestamibi for radioguided surgery of primary hyperparathyroidism.
    Rubello D; Piotto A; Medi F; Gross MD; Shapiro B; Erba P; Mariani G; Pelizzo MR;
    Eur J Surg Oncol; 2005 Mar; 31(2):191-6. PubMed ID: 15698737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism.
    Neumann DR; Obuchowski NA; Difilippo FP
    J Nucl Med; 2008 Dec; 49(12):2012-7. PubMed ID: 18997051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent or persistent hyperparathyroidism.
    Wells SA; Debenedetti MK; Doherty GM
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N158-62. PubMed ID: 12412795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reexploration and angiographic ablation for hyperparathyroidism.
    McIntyre RC; Kumpe DA; Liechty RD
    Arch Surg; 1994 May; 129(5):499-503; discussion 504-5. PubMed ID: 8185472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative sestamibi scanning and surgical findings at bilateral, unilateral, or minimal reoperation for recurrent hyperparathyroidism after subtotal parathyroidectomy in patients with multiple endocrine neoplasia type 1.
    Shepherd JJ; Burgess JR; Greenaway TM; Ware R
    Arch Surg; 2000 Jul; 135(7):844-8. PubMed ID: 10896380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing face of reoperative parathyroidectomy: a single-centre comparison of 147 parathyroid reoperations.
    Camenzuli C; DiMarco AN; Isaacs KE; Grant Y; Jackson J; Alsafi A; Harvey C; Barwick TD; Tolley N; Palazzo FF
    Ann R Coll Surg Engl; 2021 Jan; 103(1):29-34. PubMed ID: 32829647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective parathyroid venous sampling in reoperative parathyroid surgery: A key localization tool when noninvasive tests are unrevealing.
    Zolin SJ; Crawford K; Rudin AV; Harsono H; Krishnamurthy VD; Jin J; Berber E; Siperstein A; Shin JJ
    Surgery; 2021 Jan; 169(1):126-132. PubMed ID: 32651054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effectiveness of localization studies and intraoperative parathormone monitoring in patients undergoing reoperative parathyroidectomy for persistent or recurrent hyperparathyroidism.
    Parikh PP; Farra JC; Allan BJ; Lew JI
    Am J Surg; 2015 Jul; 210(1):117-22. PubMed ID: 26072281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization studies in patients with hyperparathyroidism.
    Mitchell BK; Merrell RC; Kinder BK
    Surg Clin North Am; 1995 Jun; 75(3):483-98. PubMed ID: 7747254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic value of parathyroid hormone washout after fine-needle aspiration of suspicious cervical lesions in patients with hyperparathyroidism.
    Abdelghani R; Noureldine S; Abbas A; Moroz K; Kandil E
    Laryngoscope; 2013 May; 123(5):1310-3. PubMed ID: 23553068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.